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In this issue of Developmental Cell, Asokan and colleagues (2014) report that the phospholipase Cg (PLCg)-
diacyl glycerol (DAG) protein kinase Ca (PKCa) signaling axis inhibits actomyosin bundling. This preferen-
tially occurs at the leading edge of chemotactic mesenchymal cells via noncanonical phosphorylation of
the regulatory light chain (RLC) of nonmuscle myosin II.The mechanisms that govern chemotaxis
are relatively well described in amoeboid-
migrating cells, e.g., leukocytes. However,
the physiological relevance of chemo-
taxis and the molecular circuits that
control this process in mesenchymal cells
are less well characterized (Friedl and
Wolf, 2010). Leukocyte chemotaxis has
garnered more attention because migra-
tion is an essential event in the life cycle
of these cells. For example, lymphocytes
migrate through different anatomic loca-
tions (e.g., lymph nodes) as they patrol
the organism, seeking foreign antigens.
These ‘‘migratory trails’’ are determined
by gradients of soluble and immobilized
chemoattractants (Nourshargh et al.,
2010). Lymphocytes and other leukocytes
(e.g., monocytes and neutrophils) also
follow chemotactic cues as they develop
their effector function, for example
during inflammatory infiltration into injured
tissues (Zabel et al., 2014). On the
other hand, mesenchymal cells seldom
migrate chemotactically; rare instances
of such behavior include organogenesis,
response to mechanical injury (wound
healing), or de novo plasticity processes,
such as regeneration, angiogenesis, and
tumor invasion (Friedl and Wolf, 2010).
In amoeboid-migrating cells, chemo-
kines and other chemotactic factors bind
to G protein-coupled receptors (GPCRs)
that initiate signaling cascades, leading
to receptor and cytoskeletal reorgani-
zation to enable directed cell movement
(Swaney et al., 2010). However, most
mesenchymal cells preferentially undergo
chemotaxis toward growth factors that
bind to Tyr kinase-type receptors, e.g.,
EGF, PDGF, or VEGF (Roussos et al.,
2011). These two types of chemical
cues, acting through common and unique
mediators, drive the component pro-cesses of cell migration. These include
front-back cell polarization, protrusion in
the direction of the higher concentration
of the chemotactic gradient, assembly
and disassembly of cell-matrix adhesion,
and contractility and retraction of the rear.
Protrusion, i.e., the extension of the cell
in the direction of the higher concentration
of the chemotactic gradient, relies on de
novo actin polymerization—controlled by
the Arp2/3 complex—to formdendritic lat-
tices of F-actin. However, the specific
roles of other cytoskeletal components
during this process are less clear. For
example, nonmuscle myosin II (NMII) is
not required for protrusion but mediates
retraction of the rear in mesenchymal
and amoeboid cells (Vicente-Manzanares
et al., 2009). In mesenchymal cells, NMII
supports the formation of complex actin
and adhesive structures. On the contrary,
amoeboid-moving cells do not display
stable focal adhesions or complex actin
structures. However, they require NMII-
mediated contractility to ‘‘squeeze’’ their
nucleus through narrow gaps such as
endothelial cell-cell junctions during extra-
vasation and dense extracellular matrix
zones in interstitial migration (Nourshargh
et al., 2010; Jacobelli et al., 2013).
In mesenchymal cells, large adhesions
and their associated actomyosin bundles
(for example, stress fibers) locally inhibit
protrusion (Vicente-Manzanares et al.,
2011). Therefore, an outstanding question
in mesenchymal migration was how
such NMII-mediated assemblies are pre-
vented at protrusive edges, particularly in
chemotaxing cells. In an elegant study
published in this issue of Developmental
Cell, Asokan and colleagues (2014)
uncover a mechanism of NMII inhibition
at the leading edge of growth factor-stim-
ulated chemotactic fibroblasts (Figure 1).Developmental Cell 31, DThrough this mechanism, chemotactic
signals prevent the local assembly of large
actomyosin bundles, thereby permitting
protrusion at the leading edge. The
authors use a microfluidic device that
enables visualizing directional migration
in response to platelet-derived growth
factor (PDGF). They initially determine
that several crucial signaling intermedi-
ates that control amoeboid chemotaxis,
such as phosphatidyl inositol 3-kinase
(PI3K)/PTEN and mTOR, are not involved
in mesenchymal chemotaxis to PDGF.
Next, they use chemical and genetic
approaches to examine the contribution
of NMII to PDGF-mediated chemotaxis.
Their results indicate that NMII-A is neces-
sary for cells to respond properly to the
chemotactic gradient.
The authors then focus on noncanoni-
cal regulation of the regulatory light chain
(RLC) of NMII, particularly via phospho-
rylation of serine 1 (Ser1) and serine 2
(Ser2). These are PKC-dependent phos-
phoregulatory sites previously shown to
control NMII reorganization in response
to PDGF (Komatsu and Ikebe, 2007).
The authors show that cells expressing a
nonphosphorylatable mutant of RLC in
Ser1 and Ser2 (S1AS2A) are not able to
navigate properly in PDGF gradients.
This phenotype is similar to that induced
by chemical or genetic inhibition of the
only isoform of PKC (PKCa) present
in these cells. Interestingly, wild-type
fibroblasts display chemorepulsion in
a gradient of Go¨6976, a chemical PKC
inhibitor. Conversely, S1AS2A RLC-
expressing cells (and also PKCa-deficient
cells) do not display chemorepulsion.
Together, these data indicate that PKCa
regulates the orientation of migrating fi-
broblasts in chemoattractant or chemore-
pelent gradients upstream of RLC.ecember 22, 2014 ª2014 Elsevier Inc. 669
Figure 1. PKCa Inhibits Nonmuscle Myosin II Assembly at the Leading Edge via
Phosphorylation of the RLC
Mesenchymal chemotactic cell responds to a linear gradient of PDGF (from higher concentration on the
right to lower concentration on the left, green to white). PDGF binding to PDGFR triggers PLCg activation,
which produces DAG. DAG activates PKCa, which inhibits nonmuscle myosin II (NMII) assembly via
its regulatory light chain (RLC) serines 1 and 2 (S1/S2). This enables dendritic actin polymerization
(yellow dots, right pole) and nascent adhesion assembly (red dots, right pole) in the lamellipodium.
At the lamellum, myosin II activation and decreased PKCa phosphorylation of RLC S1/2 enables
initial actomyosin assembly and adhesion maturation (red ovals). At the cell body and rear (left), fully
assembled NMIIA and NMIIB (shown as light and dark blue circles) support highly organized actin bundles
(archetypical stress fibers are shown decorated with NMIIA and NMIIB) that block protrusion from
these regions. The nucleus is also shown in pale red.
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glycerol (DAG) generated in the hydrolysis
of phosphatydilinositol (4,5) biphosphate
(PIP2) by PLCg. To address the relevance
of this pathway in PDGF-induced fibro-
blast chemotaxis, the authors deplete
PLCg and reveal its crucial role in chemo-
tactic navigation. Using a PKCg-based
fluorescent reporter, they visualize an
asymmetric accumulation of DAG toward
the higher concentration of the gradient.
They also find that gradients of a mem-
brane-permeable, functional DAG analog
(PMA) promote chemotaxis indepen-
dently of PLCg. PMA-triggered chemo-670 Developmental Cell 31, December 22, 20taxis still requires PKCa and is inhibited
by expression of RLC S1AS2A. This
indicates that these molecules are down-
stream of PMA in the signaling pathways
that mediate chemotaxis. Interestingly,
gradients of the NMII inhibitor blebbistatin
also induce chemotaxis even in S1AS2A-
expressing cells, suggesting that polar-
ized inhibition of NMII assembly permits
directional migration.
This study argues that PKC-dependent
inhibition of RLC-mediated actomyosin
assembly at the leading edge is crucial
for the development of an adequate
chemotactic response. Outstanding ques-14 ª2014 Elsevier Inc.tions remain. For example, what is the
ability of other PKC isoforms expressed
in different cell lineages to trigger RLC
phosphorylation and local NMII disas-
sembly? The contribution of other mecha-
nisms that control protrusiveness, i.e.,
adhesive signaling and crosstalk between
growth factor and integrin-dependent
signaling pathways also need to be
addressed. However, this study convinc-
ingly uncovers a regulatory circuit that
controls the migratory ability of mesen-
chymal cells in response to chemotactic
signals. It also connects the dots between
the activating signals that promote protru-
sion and the inhibition of anti-protrusive
mediators.REFERENCES
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